Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

BUY
$0.22 - $0.58 $476,931 - $1.26 Million
2,167,871 Added 230.48%
3,108,473 $808,000
Q3 2023

Oct 26, 2023

SELL
$0.47 - $1.87 $114,216 - $454,436
-243,014 Reduced 20.53%
940,602 $554,000
Q2 2023

Aug 10, 2023

BUY
$1.44 - $2.26 $14,408 - $22,613
10,006 Added 0.85%
1,183,616 $1.78 Million
Q1 2023

May 04, 2023

BUY
$1.1 - $2.86 $458,837 - $1.19 Million
417,125 Added 55.14%
1,173,610 $2.02 Million
Q4 2022

Feb 09, 2023

BUY
$0.92 - $96.0 $108,472 - $11.3 Million
117,905 Added 18.46%
756,485 $869,000
Q3 2022

Nov 10, 2022

SELL
$2.22 - $82.2 $966,110 - $35.8 Million
-435,185 Reduced 40.53%
638,580 $1.67 Million
Q2 2022

Jul 26, 2022

BUY
$2.0 - $4.78 $260,196 - $621,868
130,098 Added 13.79%
1,073,765 $2.33 Million
Q1 2022

Jun 02, 2022

BUY
$3.34 - $6.05 $2.64 Million - $4.79 Million
791,916 Added 521.85%
943,667 $4.4 Million
Q1 2022

May 10, 2022

SELL
$3.34 - $6.05 $2.05 Million - $3.71 Million
-612,494 Reduced 80.14%
151,751 $707,000
Q4 2021

Feb 08, 2022

SELL
$5.46 - $9.69 $2.01 Million - $3.56 Million
-367,886 Reduced 32.5%
764,245 $4.63 Million
Q3 2021

Nov 15, 2021

BUY
$4.64 - $7.94 $5.25 Million - $8.99 Million
1,132,131 New
1,132,131 $8.15 Million

Others Institutions Holding MYMD

About MyMD Pharmaceuticals, Inc.


  • Ticker MYMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,470,000
  • Market Cap $67.5M
  • Description
  • MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...
More about MYMD
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.